Request Demo
Last update 28 Sep 2025
Influenza vaccine (Split virion) (Zhifei Longcom)
Last update 28 Sep 2025
Overview
Basic Info
Drug Type Prophylactic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (23 Sep 2025), |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Influenza vaccine (Split virion) (Zhifei Longcom)CTR20130457
流感病毒裂解疫苗的安全性和免疫原性临床试验
[Translation] Clinical trials on the safety and immunogenicity of influenza virus split vaccines
100 Clinical Results associated with Influenza vaccine (Split virion) (Zhifei Longcom)
Login to view more data
100 Translational Medicine associated with Influenza vaccine (Split virion) (Zhifei Longcom)
Login to view more data
100 Patents (Medical) associated with Influenza vaccine (Split virion) (Zhifei Longcom)
Login to view more data
100 Deals associated with Influenza vaccine (Split virion) (Zhifei Longcom)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Influenza, Human | China | 23 Sep 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free